Modulatory effects of NDP-MSH in the regenerating liver after partial hepatectomy in rats.
Lonati. Caterina C; Carlin. Andrea A; Leonardi. Patrizia P; Valenza. Franco F; Bosari. Silvano S; Catania. Anna A; Gatti. Stefano S
Key Findings
- Melanotan‑I altered the expression of many liver genes after partial hepatectomy, especially chemokines and their receptors.
- The peptide strongly enhanced the IL‑6/STAT/SOCS signaling cascade during early liver regeneration.
- It reduced the decline of IκBα protein and modestly influenced cell‑cycle mediators, yet did not significantly accelerate final liver mass recovery.
Practical Outcomes
- A single dose of melanotan‑I may provide mild anti‑inflammatory or liver‑protective signals after acute injury, but there’s no clear evidence it speeds liver regeneration or offers measurable health benefits for longevity. Biohackers should view this as an early‑stage animal finding, not a ready‑to‑use protocol, and await human data before considering it for metabolic or performance enhancement.
Summary
In rats, a single injection of melanotan‑I (NDP‑MSH) before removing 70% of the liver changed many gene messages, boosted an inflammation‑related IL‑6/STAT signaling pathway, and lessened the drop of a protein called IκBα, but it didn’t noticeably speed up the liver’s overall regrowth.
Abstract
Melanocortins are endogenous peptides that exert protective actions on the host physiology. The broad modulatory effects of these molecules suggest that they might influence the mediator network induced during liver regeneration. The research aim was to determine if melanocortin treatment alters liver molecular changes induced by partial hepatectomy (PH). Rats under isoflurane anesthesia were subjected to standard 70% PH or sham surgery. Animals received a single i.v. injection of Nle4, DPhe7-α-melanocyte stimulating hormone (NDP-MSH) or saline 30 min before surgery. Sacrifice was performed at time intervals between 4 and 72 h. A preliminary screening based on TaqMan low-density array (TLDA) identified 71 transcripts altered by PH. Real-time PCR analysis revealed that NDP-MSH modulated the expression of a substantial proportion of these transcripts including several chemokines and their receptors. The critical signaling pathway interleukin-6 (IL-6)/signal transducer and activator of transcription (STAT)/suppressor of cytokine signaling (SOCS) was significantly enhanced by NDP-MSH. Further, peptide treatment considerably reduced the decline of IκBα protein caused by PH. Although the final organ regeneration was not substantially affected, NDP-MSH modulated expression of cell cycle mediators and exerted subtle influences on hepatocyte replication. Most of the changes brought about by NDP-MSH, a peptide approved for clinical use, should be salutary during liver regeneration.
Study Information
pubmed
2013